title: The Long-term Release of Antibiotics From Monolithic Nonporous Polymer Implants for Use as Tympanostomy Tubes.
abstract: A technology is elaborated for the fabrication of a novel tympanostomy tube (TT) from solidified polymer melts (Elvax and Polyurethane) and antibiotics (Ciprofloxacin and Usnic acid) for insertion into tympanic membrane (ear drum) according to the established surgical procedure. The long-term in vitro release kinetics of the antibiotics into liquid water has been assessed using standard methods. The measured kinetic curves revealed two stages of antibiotic release into the finite space. During the first stage (fast), the fast release rate is almost invariant and is determined by the diffusion through the steady diffusion layer formed due to solution agitation. In this first stage, the influence of the initial internal transport is weak because it takes place at negligibly small distance from interface and accordingly, at negligibly concentration drop. After the antibiotic concentration decreases within the much broader layer of matrix near interface, the internal transport becomes important. This manifests itself as the second stage in measured kinetics of release curves which is characterized by a gradual decrease in rate. The minimum inhibition concentrations of three antibiotics/antimicrobial compounds for four bacterial species were measured. The first stage of fast release from the polymer implant lasts 6 days at a polymer loading by Ciprofloxacin (0.03 g/cm(3)) and this was sufficient for preventing biofilm formation on the surface of the implant material. The measured kinetic curves of drug release showed more rapid decrease in the release rate compared to the Higuchi approximation. Comparison with existing theories, which account for the finite rate of drug dissolution, showed that this may explain the observed deviation from the diffusion-controlled Higuchi model. Large dimensions of drug particles and their aggregation retard the dissolution stage and consequently the release rate. Melt blending was found to cause the drug particle aggregation within polymer matrixes which was confirmed by microscopic reexamination of the polymer implant materials.
authors: Novaflux Technologies, 1 Wall Street, Princeton, NJ 08540, U.S.A.
authors: Mohamed E
authors: ME
authors: Labib
authors: Charles J
authors: CJ
authors: Brumlik
authors: Paul
authors: P
authors: Stoodley
authors: Stanislav S
authors: SS
authors: Dukhin
authors: Theodore
authors: T
authors: Davidson
authors: Yacoob
authors: Y
authors: Tabani
references: J Control Release. 2003 Oct 30;92(3):331-9
references: 14568413
references: J Pharm Sci. 1970 Mar;59(3):353-7
references: 5416178
references: J Control Release. 1998 Mar 2;52(1-2):141-8
references: 9685944
references: Antimicrob Agents Chemother. 2004 Nov;48(11):4360-5
references: 15504865
references: J Pharm Sci. 1977 May;66(5):662-8
references: 874747
references: J Control Release. 1998 Oct 30;55(1):99-101
references: 9795023
references: J Pharm Sci. 1985 Jun;74(6):685-7
references: 2410591
references: J Control Release. 2002 Nov 7;84(1-2):1-13
references: 12399163
references: Chem Rev. 1999 Nov 10;99(11):3181-98
references: 11749514
references: JAMA. 2006 Jul 12;296(2):202-11
references: 16835426
references: Photochem Photobiol. 2005 Nov-Dec;81(6):1447-9
references: 16107188
references: J Pharm Sci. 1961 Oct;50:874-5
references: 13907269
references: J Pharm Sci. 1977 May;66(5):654-62
references: 874746